2.4. Pancreatic Cancer with High Four-Gene Sore Have Higher KRAS and CDKN2A Gene Alterations, and Enhanced Signaling of KRAS, p53, TGF-β, and E2F Target Pathways. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.